{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:38:21Z","timestamp":1791319101107,"version":"4.3.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.mce.2011.06.038","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T08:49:51Z","timestamp":1311410991000},"page":"266-272","source":"Crossref","is-referenced-by-count":113,"title":["Aldosterone, mineralocorticoid receptor, and heart failure"],"prefix":"10.1016","volume":"350","author":[{"given":"Smail","family":"Messaoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feriel","family":"Azibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Delcayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Jaisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2011.06.038_b0195","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1161\/01.RES.0000102404.81461.25","article-title":"Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine\u2013immune interface","volume":"93","author":"Ahokas","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2011.06.038_b0005","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.mce.2011.06.038_b0265","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.722009","article-title":"Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells","volume":"116","author":"Ambroisine","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0115","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ahj.2010.06.049","article-title":"Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial","volume":"160","author":"Beygui","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.mce.2011.06.038_b0030","first-page":"720","article-title":"2-Methyl-9(alpha)-chlorocortisol, a new synthetic mineralocorticoid with unusually intense nephrotoxic actions","volume":"75","author":"Bois","year":"1956","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.mce.2011.06.038_b0395","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: effects on the kidney and cardiovascular system","volume":"6","author":"Briet","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.mce.2011.06.038_b0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2011.06.038_b0320","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/en.130.1.430","article-title":"Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter","volume":"130","author":"Couette","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.06.038_b0315","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mce.2011.06.038_b0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3317\/jraas.2006.005","article-title":"Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart","volume":"7","author":"De Mello","year":"2006","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.mce.2011.06.038_b0185","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","article-title":"Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling","volume":"52","author":"Di Zhang","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0325","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1517\/13543784.10.5.943","article-title":"The spironolactone renaissance","volume":"10","author":"Doggrell","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.mce.2011.06.038_b0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/eurheartj\/ehn543","article-title":"Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials","volume":"30","author":"Ezekowitz","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mce.2011.06.038_b0370","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","article-title":"Multiple aspects of mineralocorticoid selectivity","volume":"280","author":"Farman","year":"2001","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.mce.2011.06.038_b0400","first-page":"H2035","article-title":"Coronary endothelial dysfunction after cardiomyocyte-specific mineralocorticoid receptor overexpression","volume":"300","author":"Favre","year":"2011","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2011.06.038_b0340","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1633591100","article-title":"Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor","volume":"100","author":"Fjeld","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2011.06.038_b0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cardiores.2005.03.001","article-title":"Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction","volume":"67","author":"Fraccarollo","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2011.06.038_b0230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.107.100941","article-title":"Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response","volume":"51","author":"Fraccarollo","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0210","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.110.983023","article-title":"Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction","volume":"123","author":"Fraccarollo","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0345","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor","volume":"53","author":"Funder","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0170","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0180","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00424-008-0616-0","article-title":"Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?","volume":"458","author":"Gekle","year":"2009","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.mce.2011.06.038_b0300","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1161\/CIRCULATIONAHA.108.805804","article-title":"Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins","volume":"119","author":"Gomez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2009.02.005","article-title":"New aspects of rapid aldosterone signaling","volume":"308","author":"Grossmann","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.06.038_b0025","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"Guder","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0250","doi-asserted-by":"crossref","first-page":"H1484","DOI":"10.1152\/ajpheart.01000.2010","article-title":"Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in transgenic model of Raas overexpression","volume":"300","author":"Habibi","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2011.06.038_b0365","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/en.2010-0099","article-title":"The mineralocorticoid receptor is a constitutive nuclear factor in cardiomyocytes due to hyperactive nuclear localization signals","volume":"151","author":"Hernandez-Diaz","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.06.038_b0080","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2133.1988.tb02571.x","article-title":"Tolerance of spironolactone","volume":"118","author":"Hughes","year":"1988","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.mce.2011.06.038_b0390","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2011.06.038_b0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.110.164962","article-title":"The mineralocorticoid receptor in heart: different effects in different cells","volume":"57","author":"Jaisser","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0160","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2011.06.038_b0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3565(25)25602-6","article-title":"Pharmacology of a new steroid that blocks salt activity of aldosterone and desoxycorticosterone","volume":"126","author":"Kagawa","year":"1959","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mce.2011.06.038_b0255","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/hr.2010.277","article-title":"Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats","volume":"34","author":"Kimura","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.mce.2011.06.038_b0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0960-0760(03)00198-5","article-title":"The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat","volume":"85","author":"Konishi","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.06.038_b0220","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0295","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cardiores.2005.05.009","article-title":"Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes","volume":"67","author":"Lalevee","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2011.06.038_b0355","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1210\/en.2010-0237","article-title":"Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart","volume":"151","author":"Latouche","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.06.038_b0125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-141-9-200411020-00011","article-title":"Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction","volume":"141","author":"Lee","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.mce.2011.06.038_b0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lombes","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2011.06.038_b0215","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.110.163287","article-title":"Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function","volume":"57","author":"Lother","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0245","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1210\/en.2008-1296","article-title":"Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta","volume":"150","author":"Luther","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.06.038_b0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.mce.2011.06.038_b0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mce.2003.10.008","article-title":"The 45-year story of the development of an anti-aldosterone more specific than spironolactone","volume":"217","author":"Menard","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.06.038_b0050","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0022-4731(81)90046-7","article-title":"Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta","volume":"14","author":"Meyer","year":"1981","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.mce.2011.06.038_b0360","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0405","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mce.2011.06.038_b0285","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/eurheartj\/ehi478","article-title":"Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction","volume":"26","author":"Milliez","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mce.2011.06.038_b0235","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/eurheartj\/ehn277","article-title":"Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone","volume":"29","author":"Mulder","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mce.2011.06.038_b0410","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1096\/fj.09-147926","article-title":"The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure","volume":"24","author":"Nguyen Dinh Cat","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.mce.2011.06.038_b0260","doi-asserted-by":"crossref","first-page":"R946","DOI":"10.1152\/ajpregu.00402.2006","article-title":"Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker","volume":"292","author":"Ohtani","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2011.06.038_b0110","first-page":"103","article-title":"Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients","volume":"59","author":"Orea-Tejeda","year":"2007","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.mce.2011.06.038_b0175","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/CIRCULATIONAHA.104.503706","article-title":"Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias","volume":"111","author":"Ouvrard-Pascaud","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1440-1681.1987.tb02422.x","article-title":"High affinity aldosterone binding sites (type I receptors) in rat heart","volume":"14","author":"Pearce","year":"1987","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.mce.2011.06.038_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00877755","article-title":"\u201cEscape\u201d of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy","volume":"9","author":"Pitt","year":"1995","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.mce.2011.06.038_b0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.06.038_b0095","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.06.038_b0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mce.2011.06.038_b0130","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","article-title":"Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a Double-blind, Placebo-controlled Study in Patients with Chronic Heart Failure (the PEARL-HF) trial","volume":"32","author":"Pitt","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mce.2011.06.038_b0310","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.108.184044","article-title":"Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart","volume":"104","author":"Qu","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2011.06.038_b0150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.24.1.30","article-title":"Increased cardiac types I and III collagen mRNAs in aldosterone\u2013salt hypertension","volume":"24","author":"Robert","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0020","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn\u2019s adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0350","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/HYPERTENSIONAHA.108.114223","article-title":"Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes","volume":"52","author":"Rossier","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2011.06.038_b0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrcardio.2009.244","article-title":"Heart failure: aldosterone antagonists are underused by clinicians","volume":"7","author":"Samuel","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.mce.2011.06.038_b0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/FJC.0b013e3181fe1250","article-title":"Mitochondria-targeted cardioprotection in aldosteronism","volume":"57","author":"Shahbaz","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.mce.2011.06.038_b0385","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2011.06.038_b0290","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1540-8167.2006.00372.x","article-title":"Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure","volume":"17","author":"Shroff","year":"2006","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.mce.2011.06.038_b0140","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2011.06.038_b0165","doi-asserted-by":"crossref","first-page":"H1880","DOI":"10.1152\/ajpheart.01319.2007","article-title":"RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension","volume":"294","author":"Sun","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2011.06.038_b0015","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2011.06.038_b0380","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/mol.106.031112","article-title":"The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor","volume":"71","author":"Takeda","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2011.06.038_b0145","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2011.06.038_b0190","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/1389450033490948","article-title":"Aldosteronism in heart failure: a proinflammatory\/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets","volume":"4","author":"Weber","year":"2003","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.mce.2011.06.038_b0335","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1043-2760(00)00270-8","article-title":"Aldosterone and the heart","volume":"11","author":"Young","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.06.038_b0045","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2011.06.038_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0303-7207(02)00041-2","article-title":"Steroidogenic enzyme gene expression in the human brain","volume":"190","author":"Yu","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.06.038_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.06.038_b0280","doi-asserted-by":"crossref","first-page":"H336","DOI":"10.1152\/ajpheart.01307.2005","article-title":"ANG II-induced cardiac molecular and cellular events: role of aldosterone","volume":"291","author":"Zhao","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2011.06.038_b0205","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/hr.2010.159","article-title":"From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation","volume":"33","author":"Zia","year":"2010","journal-title":"Hypertens. Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711003716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711003716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T03:32:08Z","timestamp":1741318328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720711003716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0303720711003716"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2011.06.038","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}